Human medicines European public assessment report (EPAR): Travatan, travoprost, Date of authorisation: 27/11/2001, Revision: 32, Status: Authorised

Human medicines European public assessment report (EPAR): Travatan, travoprost, Date of authorisation: 27/11/2001, Revision: 32, Status: Authorised

Human medicines European public assessment report (EPAR): Simbrinza, brinzolamide,brimonidine tartrate, Date of authorisation: 18/07/2014, Revision: 13, Status: Authorised

Human medicines European public assessment report (EPAR): Simbrinza, brinzolamide,brimonidine tartrate, Date of authorisation: 18/07/2014, Revision: 13, Status: Authorised

Human medicines European public assessment report (EPAR): Nevanac, nepafenac, Date of authorisation: 11/12/2007, Revision: 21, Status: Authorised

Human medicines European public assessment report (EPAR): Nevanac, nepafenac, Date of authorisation: 11/12/2007, Revision: 21, Status: Authorised

Human medicines European public assessment report (EPAR): Elahere, mirvetuximab soravtansine, Date of authorisation: 14/11/2024, Revision: 2, Status: Authorised

Human medicines European public assessment report (EPAR): Elahere, mirvetuximab soravtansine, Date of authorisation: 14/11/2024, Revision: 2, Status: Authorised

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

randomness